Technology
Health
Biotechnology
Scholar Rock
$12.869876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$12.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.29 (-2.21%) As of 12:10 PM EDT today
-$0.29 (-2.21%) Today
Why Robinhood?
You can buy or sell Scholar Rock and other stocks, options, ETFs, and crypto commission-free!
About SRRK
Scholar Rock Holding Corporation Common Stock, also called Scholar Rock, is a biopharmaceutical company, which engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Read More Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
Employees
65
Headquarters
Cambridge, Massachusetts
Founded
2012
Market Cap
344.76M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
130.29K
High Today
$13.23
Low Today
$12.64
Open Price
$13.23
Volume
49.60K
52 Week High
$30.00
52 Week Low
$12.64
Collections
Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2018 IPO
US
North America
Price Paid on Robinhood
27% Lower
Right Now
52 Week Low
$13.09
Average Price Paid
$17.53
52 Week High
$30.00
SRRK Earnings
-$1.39
-$1.07
-$0.74
-$0.42
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 8, After Hours